Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treprostinil liposomal - Pharmosa BioPharm

Next Previous
Search
Drug Profile

Treprostinil liposomal - Pharmosa BioPharm

Alternative Names: L-606; liposomal treprostinil controlled release - Pharmosa BioPharm; liposomal treprostinil sustained release - Pharmosa BioPharm

Latest Information Update: 27 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pharmosa Biopharm
  • Class Acetic acids; Antifibrotics; Antihypertensives; Cyclopentanes; Naphthalenes; Prostaglandins; Skin disorder therapies; Small molecules; Vasodilators
  • Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pulmonary arterial hypertension
  • Phase I Pulmonary hypertension

Most Recent Events

  • 17 May 2024 Adverse events data from a phase III trial in Pulmonary arterial hypertension presented at the 120th International Conference of the American Thoracic Society (ATS-2024)
  • 08 Jan 2024 Liquidia Technologies plans a phase III trial for pulmonary hypertension in 2024
  • 05 Jan 2024 Liquidia Technologies has a successful Type C meeting with the US FDA and agrees on the registration requirements for L 606, using the 505(b) regulatory pathway

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top